CROI 2013: Retrovirus Conference Starts Sunday in Atlanta


The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) kicks off Sunday, March 3, at the Georgia World Congress Center in Atlanta. will be on site next week to bring you breaking news coverage on HIV and hepatitis C.

Look for reports from the team and our content partners at NAM/ starting Monday. Sign up for our email newsletter to get the latest headlines and follow us on Twitter @HIVandHepatitis.

CROI is one of the major annual scientific meetings about HIV/AIDS, bringing together top researchers from around the world. Some of the topics to be discussed this year include research towards a cure for HIV, new antiretroviral therapies, management of HIV- and treatment-related complications, biomedical prevention, and the cascade of care.

As always, CROI will include studies of HIV/HBV and HIV/HCV coinfection, but last year -- with the advent of the first direct-acting antiviral drugs (DAAs) for hepatitis C -- the conference began including presentations on HCV monoinfection as well. This year data will be presented on DAAs including sofosbuvir, the newly-named ledipasvir (previously known as GS-5885), simeprevir, and an all-oral combo from AbbVie (formerly Abbott).

The CROI 2013 pocket program is now available online at and abstracts will be published on the conference website after it is presented, along with webcasts of selected presentations.



20th Conference on Retroviruses and Opportunistic Infections.